1. Home
  2. Research
  3. Research Groups
  4. Infectious Diseases

Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Podzamczer D, Imaz A, Lopez-Lirola A, Knobel H, Masiá M, Fanciulli C, Hernández C, Lagarde M, Gutierrez A, Curran A, Morano L, Montero-Alonso M, Troya J, Rigo R, Casadellà M, Navarro-Alcaraz A, Ardila F, Parera M, Bernal E, Echeverria P, Estrada V, Hidalgo-Tenorio C, Macias J, Prieto P, Portilla J, Valencia E, Vivancos MJ, Rivero A.

    Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 78: 2696-2701. Number of citations: 4

    [doi:10.1093/jac/dkad285]

  • San Martín-López JV, Mesa N, Bernal-Bello D, Morales-Ortega A, Rivilla M, Guerrero M, Calderón R, Farfán AI, Rivas L, Soria G, Izquierdo A, Madroñal E, Duarte M, Piedrabuena S, Toledano-Macías M, Marrero J, de Ancos C, Frutos B, Cristóbal R, Velázquez L, Mora B, Cuenca P, Satué JÁ, Ayala-Larrañaga I, Carpintero L, Lara C, Llerena ÁR, García V, García de Viedma V, Prieto S, González-Pereira N, Bravo C, Mariño C, Lechuga LA, Tarancón J, Gonzalo S, Moreno S, Ruiz-Giardin JM.

    Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors.

    VIRUSES-BASEL . 15(9): . Number of citations: 6

    [doi:10.3390/v15091839]

  • Sánchez-Conde M, Alba C, Castro I, Dronda F, Ramírez M, Arroyo R, Moreno S, Rodríguez JM, Brañas F.

    Comparison of the Fecal Bacteriome of HIV-Positive and HIV-Negative Older Adults.

    Biomedicines . 11(8): . Number of citations: 3

    [doi:10.3390/biomedicines11082305]

  • Espineira S, Flores-Piñas M, Chafino S, Viladés C, Negredo E, Fernández-Arroyo S, Mallolas J, Villar B, Moreno S, Vidal F, Rull A, Peraire J.

    Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV.

    Frontiers in immunology . 14: 1228795-1228795. Number of citations: 9

    [doi:10.3389/fimmu.2023.1228795]

  • Hernando V, Suárez L, Gutiérrez G, López JC, Navarro-Soler R, Cabello A, Sanz J, Suarez-García I, Fernández MT, Losa JE, Pérez JL, Ramos-Ruperto L, Pérez-Elías MJ, Aayuni WBCE, Cuesta M, González G, Izquierdo A, Viloria L, López I, Martínez E, Castrillejo D, Jaume Amengual MG, Belmonte MA, Arraiza A, de la Torre J, Miqueleiz E, Marcos H, Ruiz-Algueró M, Villegas T, Simón L, Diaz A.

    Vaccination trends in people with HIV infection participanting in the hospital-based survey of patients infected with HIV, 2006-2021.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . : .

    [doi:10.1016/j.eimce.2023.07.006]

  • Berna-Rico E, Chamorro-Tojeiro S, Pérez-González A, Pérez-García B.

    Superinfected scabies.

    MEDICINA CLINICA . 162(3): 145-145.

    [doi:10.1016/j.medcli.2023.06.048]

  • Palacios R, Gómez-Ayerbe C, Casado JL, Tejerina F, Montes ML, Castaño M, Ocampo A, Rial D, Ribera E, Galindo MJ, Hidalgo C, Fariñas C, Montero M, Payeras T, Fanjul F, de la Torre J, Santos J.

    Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119

    HIV MEDICINE . 24(8): 933-937. Number of citations: 4

    [doi:10.1111/hiv.13489]

  • Moreno S, Rivero A, Ventayol P, Falcó V, Torralba M, Schroeder M, Neches V, Vallejo-Aparicio LA, Mackenzie I, Turner M, Harrison C.

    Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain.

    Infectious diseases and therapy . 12(8): 2039-2055. Number of citations: 10

    [doi:10.1007/s40121-023-00840-y]

  • Norman FF, Gonzalez-Sanz M, Gullón-Peña B, Chamorro-Tojeiro S, Rosas M, Crespillo-Andujar C, Monge-Maillo B, Comeche B, Corbacho-Loarte MD, Arcas C, Peña I, Tenorio MC, Lopez-Vélez R, Pérez-Molina JA.

    Haemoglobinopathies in mobile populations from sub-Saharan Africa

    JOURNAL OF TRAVEL MEDICINE . 30: .

    [doi:10.1093/jtm/taad115]

  • Pérez-Molina JA, Crespillo-Andújar C, Trigo E, Chamorro S, Arsuaga M, Olavarrieta L, Navia B, Martín O, Monge-Maillo B, Norman FF, Lanza VF, Serrano-Villar S.

    Chagas disease is related to structural changes of the gut microbiota in adults with chronic infection (TRIPOBIOME Study).

    PLOS NEGLECTED TROPICAL DISEASES . 17(7): . Number of citations: 5

    [doi:10.1371/journal.pntd.0011490]

  • Barbero Allende JM, Gómez-Junyent J, Sorlí Redó L, Rodríguez-Pardo D, Murillo Rubio Ó, Fernández Sampedro M, Escudero-Sánchez R, García Gutiérrez M, Portillo ME, Sancho I, Rico Nieto A, Guio Carrión L, Soriano A, Morata Ruiz L.

    Description of reinfection of joint prosthesis after 2-stage replacement (infection of the 2nd stage prosthesis): A multicenter study.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . : .

    [doi:10.1016/j.eimce.2023.07.002]

  • Serrano-Villar S, Tincati C, Raju SC, Sáenz JS, Moreno E, Bargiela R, Cabello-Ubeda A, Sendagorta E, Kurz A, Perez Molina JA, de Benito A, Hov JR, Fernandez-Lopez L, Muriel A, Del Campo R, Moreno S, Trøseid M, Seifert J, Ferrer M.

    Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer.

    NATURE MEDICINE . 29(7): 1738-1749. Number of citations: 15

    [doi:10.1038/s41591-023-02407-3]

  • Rosas Cancio-Suárez M, Díaz-Álvarez J, Ron R, Martínez-Sanz J, Serrano-Villar S, Moreno S, Sánchez-Conde M.

    From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications.

    PATHOGENS . 12(7): . Number of citations: 4

    [doi:10.3390/pathogens12070924]

  • Sojo-Dorado J, López-Hernández I, Hernández-Torres A, Retamar-Gentil P, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Álvarez RM, Dueñas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jiménez V, Docobo-Pérez F, Pascual Á, Rodríguez-Baño J.

    Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 78(7): 1658-1666. Number of citations: 8

    [doi:10.1093/jac/dkad147]

  • Ruiz-Cáceres I, Hermida Romero T, Guerra Merino I, Portu Zapirain J, Pérez-Mies B, Sánchez-Conde M, Riaño MA, Rubio R, Fortés Alen J, Vidal González Á, Salas Antón C, Múñez E, Sánchez Sánchez R, Corona-Mata D, Aldecoa Ansorregui I, Miró JM, Beloqui Pérez de Obanos R, Ibero C, Gómez-Román J, Fariñas MC, Tabuyo Bello T, de Alava E, Cisneros JM, Matías-Guiu X, Rivero A.

    Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections.

    Frontiers In Medicine . 10: 1151843-1151843.

    [doi:10.3389/fmed.2023.1151843]

  • Serrano-Villar, Sergio, Ferrer, Manuel.

    How the microbiome can help detect precancerous lesions and prevent anal cancer

    NATURE MEDICINE . 29(7): 1619-1620.

    [doi:10.1038/s41591-023-02421-5]

  • Puerta-Alcalde P, Monzó-Gallo P, Aguilar-Guisado M, Ramos JC, Laporte-Amargós J, Machado M, Martin-Davila P, Franch-Sarto M, Sánchez-Romero I, Badiola J, Gómez L, Ruiz-Camps I, Yáñez L, Vázquez L, Chumbita M, Marco F, Soriano A, González P, Fernández-Cruz A, Batlle M, Fortún J, Guinea J, Gudiol C, García J, Ruiz Pérez de Pipaón M, Alastruey-Izquierdo A, Garcia-Vidal C.

    Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    JOURNAL OF INFECTION . 87(1): 46-53. Number of citations: 32

    [doi:10.1016/j.jinf.2023.05.005]

  • González-Sanz M, Berzosa P, Norman FF.

    Updates on Malaria Epidemiology and Prevention Strategies

    CURRENT INFECTIOUS DISEASE REPORTS . 25(7): 131-139. Number of citations: 19

    [doi:10.1007/s11908-023-00805-9]